Gene signatures reflect the marked heterogeneity of tissue-resident macrophages

Immunology and Cell Biology

Volumn 86, Issue 3, 2008, Pages 246-254

  Gorgani, Nick N ^a   Ma, Yan ^a   Clark, Hilary F ^a  

^a GENENTECH INC   (United States)

Author keywords

Gene signature; Macrophage; Microarray expression

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA6 INTEGRIN; BETA1 INTEGRIN; CD11 ANTIGEN; CD14 ANTIGEN; CD32 ANTIGEN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; CXCL13 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GAMMA INTERFERON RECEPTOR 1; GLYCEROPHOSPHOINOSITOL INOSITOLPHOSPHODIESTERASE; GROWTH ARREST SPECIFIC PROTEIN 6; HEME OXYGENASE 1; HFE PROTEIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 1BETA; INTERLEUKIN 27; L SELECTIN; LACTADHERIN; LANGERIN; LIPOCORTIN 5; PADGEM PROTEIN; PROTEIN MD 2; SCAVENGER RECEPTOR BI; TOLL LIKE RECEPTOR 4; VASCULAR ENDOTHELIAL CADHERIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL ADHESION; CELL FUNCTION; CELL HETEROGENEITY; CONTROLLED STUDY; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; IMMUNOSURVEILLANCE; LIPID METABOLISM; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD11B; ANTIGENS, DIFFERENTIATION; CELL ADHESION; CELL LINEAGE; CELL SEPARATION; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; LIPID METABOLISM; MACROPHAGES; MICE; MULTIGENE FAMILY; ORGAN SPECIFICITY; PHAGOCYTOSIS; SIGNAL TRANSDUCTION; SOFTWARE DESIGN;

MURINAE;

EID: 41149104463     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/sj.icb.7100131     Document Type: Article

References (43)

1. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol 2005; 5: 606-616.
2. Parker GA, Picut CA. Liver immunobiology. Toxicol Pathol 2005; 33: 52-62.
3. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964.
4. Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 2005; 4: 281-286.
5. Ma Y, Pope RM. The role of macrophages in rheumatoid arthritis. Curr Pharm Des 2005; 11: 569-580.
6. Barshes NR, Wyllie S, Goss JA. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 2005; 77: 587-597.
7. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4: 71-78.
8. Greaves DR, Gordon S. Macrophage-specific gene expression: current paradigms and future challenges. Int J Hematol 2002; 76: 6-15.
9. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004; 351: 2817-2826.
10. Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB et al. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 2006; 355: 560-569.
11. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003; 100: 2610-2615.
12. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197: 711-723.
13. Han GM, Chen SL, Shen N, Ye S, Bao CD, Gu YY. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun 2003; 4: 177-186.
14. Baranzini SE, Mousavi P, Rio J, Caillier SJ, Stillman A, Villoslada P et al. Transcription-based prediction of response to IFNbeta using supervised computational methods. PLoS Biol 2005; 3: e2.
15. Abbas AR, Baldwin D, Ma Y, Ouyang W, Gurney A, Martin F et al. Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun 2005; 6: 319-331.
16. Mak PA, Laffitte BA, Desrumaux C, Joseph SB, Curtiss LK, Mangelsdorf DJ et al. Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta. J Biol Chem 2002; 277: 31900-31908.
17. Woodruff PG, Koth LL, Yang YH, Rodriguez MW, Favoreto S, Dolganov GM et al. A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med 2005; 172: 1383-1392.
18. Koike E, Hirano S, Shimojo N, Kobayashi T. cDNA microarray analysis of gene expression in rat alveolar macrophages in response to organic extract of diesel exhaust particles. Toxicol Sci 2002; 67: 241-246.
19. Schmutz C, Hulme A, Burman A, Salmon M, Ashton B, Buckley C et al. Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5. Arthritis Res Ther 2005; 7: R217-R229.
20. Grimes GR, Moodie S, Beattie JS, Craigon M, Dickinson P, Forster T et al. GPX-macrophage expression atlas: a database for expression profiles of macrophages challenged with a variety of pro-inflammatory, anti-inflammatory, benign and pathogen insults. BMC Genomics 2005; 6: 178.
21. van den Berg TK, Kraal G. A function for the macrophage F4/80 molecule in tolerance induction. Trends Immunol 2005; 26: 506-509.
22. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. Macrophage receptors and immune recognition. Annu Rev Immunol 2005; 23: 901-944.
23. McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, Baribault H et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J 1996; 15: 5647-5658.
24. Iwasaki H, Mizuno S, Wells RA, Cantor AB, Watanabe S, Akashi K. GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/ erythrocyte lineages. Immunity 2003; 19: 451-462.
25. Walsh JC, DeKoter RP, Lee HJ, Smith ED, Lancki DW, Gurish MF et al. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity 2002; 17: 665-676.
26. Nassar T, Sachais BS, Akkawi S, Kowalska MA, Bdeir K, Leitersdorf E et al. Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells. J Biol Chem 2003; 278: 6187-6193.
27. Scheuerer B, Ernst M, Durrbaum-Landmann I, Fleischer J, Grage-Griebenow E, Brandt E et al. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood 2000; 95: 1158-1166.
28. Iwakura Y. Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models. Cytokine Growth Factor Rev 2002; 13: 341-355.
29. Meyer M, Hensbergen PJ, van der Raaij-Helmer EM, Brandacher G, Margreiter R, Heufler C et al. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection. Eur J Immunol 2001; 31: 2521-2527.
30. Arce I, Martinez-Munoz L, Roda-Navarro P, Fernandez-Ruiz E. The human C-type lectin CLECSF8 is a novel monocyte/macrophage endocytic receptor. Eur J Immunol 2004; 34: 210-220.
31. Akakura S, Singh S, Spataro M, Akakura R, Kim JI, Albert ML et al. The opsonin MFGE8 is a ligand for the alphavbeta5 integrin and triggers DOCK180-dependent Rac1 activation for the phagocytosis of apoptotic cells. Exp Cell Res 2004; 292: 403-416.
32. Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, Liu Y et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 2000; 12: 71-81.
33. Helmy KY, Katschke Jr KJ, Gorgani NN, Kljavin NM, Elliott JM, Diehl L et al. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 2006; 124: 915-927.
34. Andrews NC. A genetic view of iron homeostasis. Semin Hematol 2002; 39: 227-234.
35. Shashkin P, Dragulev B, Ley K. Macrophage differentiation to foam cells. Curr Pharm Des 2005; 11: 3061-3072.
36. Osugi Y, Vuckovic S, Hart DN. Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. Blood 2002; 100: 2858-2866.
37. Roos A, Xu W, Castellano G, Nauta AJ, Garred P, Daha MR et al. Mini-review: a pivotal role for innate immunity in the clearance of apoptotic cells. Eur J Immunol 2004; 34: 921-929.
38. Affolter M, Weijer CJ. Signaling to cytoskeletal dynamics during chemotaxis. Dev Cell 2005; 9: 19-34.
39. Gao B. Cytokines, STATs and liver disease. Cell Mol Immunol 2005; 2: 92-100.
40. Cameron ER, Neil JC. The Runx genes: lineage-specific oncogenes and tumor suppressors. Oncogene 2004; 23: 4308-4314.
41. Dinarello CA. Blocking IL-1 in systemic inflammation. J Exp Med 2005; 201: 1355-1359.
42. Moses AC. Insulin resistance and type 2 diabetes mellitus: is there a therapeutic role for IGF-1? Endocr Dev 2005; 9: 121-134.
43. Wellington K, Perry CM. Efalizumab. Am J Clin Dermatol 2005; 6: 113-118; discussion 19-20.